Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Women are more likely to have long-term post-COVID symptoms than men.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 infection can significantly cause temporary hair loss.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The treatment might help COVID-19 related hair loss, but more research is needed.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

New understanding and treatments for hair loss are improving, but more research is needed.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 can cause temporary hair loss due to stress and inflammation.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Cysteine helps maintain keratin production in skin cells even when iron is low.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Microneedle made of iron oxide and PVA helps hair regrowth in alopecia treatment.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.